Cancer detection startup MetaSight acquired by Guardant Health for up to $150 million | CTech
Israeli startup MetaSight is being acquired by U.S. diagnostics company Guardant Health in a deal valued at up to $150…
Israeli startup MetaSight is being acquired by U.S. diagnostics company Guardant Health in a deal valued at up to $150…